FormWeb • mitoMYcin ophthalmic

IHS FormWeb

Approved Formulary

Search by class Show Therapeutic Classes

Staff Telephone Numbers

Add Formweb to your mobile device

Android iOS

Search results for:

mitoMYcin ophthalmic

mitoMYcin ophthalmic

Drug Name	Form	Strength	Non-Formulary	Restricted	TX Sub	Notes
Mitosol	KIT, OPHTHALMIC	0.2 mg

Display Antineoplastic Agents Class : 100000

High Alert Drug : Policy

Medication comments:

High Alert Drug: Chemotherapeutic Agents - Parenteral
• Stored separately in pharmacy. • Pharmacist reviews literature in order to to verify calculations and dose prescribed. • Two pharmacists independently verify preparation. • No telephone orders. Pre-printed order sheet available. • Chemo is administered by specially trained RNs. • 2 RNs independently verify pump settings and drug on continuous infusions prior to administration. • IV sites are assessed every 2 hours. • Drugs are transported in plastic bags/designated transport containers labeled with sticker indicating CHEMOTHERAPY DRUG.

High Alert Drug: Chemotherapeutic Agents - Parenteral

• Stored separately in pharmacy.
• Pharmacist reviews literature in order to to verify calculations and dose prescribed.
• Two pharmacists independently verify preparation.
• No telephone orders. Pre-printed order sheet available.
• Chemo is administered by specially trained RNs.
• 2 RNs independently verify pump settings and drug on continuous infusions prior to administration.
• IV sites are assessed every 2 hours.
• Drugs are transported in plastic bags/designated transport containers labeled with sticker indicating CHEMOTHERAPY DRUG.

Per policy, these hazardous drugs have special waste requirements.
Generic (Brand)	Waste Requirements
mitoMYcin ophthalmic (Mitosol)	If > 3% by weight of drug remains ⇒ BLACK BUCKET Trace amounts/uncontaminated PPE ⇒ YELLOW BUCKET

USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances. The following outlines must be followed.
generic (Brand) Route [Packaging: Manufacturer ⇒ Dispense]	Activities
mitoMYcin (Mitosol) OPTH [UD ⇒ UD]	0.2 mg vial	Stock @ IDBH? N NIOSH Table 1^A↑
Pharmacy: Receiving / Storage / Preparation Exposure Risk: minimal	• Handling/preparation PPE Requirements: n/a
	• Receiving from Distributor: Designated area/ CX gloves
	• Pharmacy Storage Area: Chemo
	• Packaging/Reconstitution Location: n/a
	• Compounding (Non-Sterile/Sterile) Location: n/a
	• Omnicell Load: No
Transport	• Transport (dose is placed inside a plastic sealable bag): Transport container Single CX gloves
Nursing: Storage / Administration Exposure Risk: low	• Handling/administration PPE Requirements: Double CX gloves and gown
	• Storage of Finished dose in Nursing Area/Procedural Area: Picked up from Pharmacy
	• Signage on Patient Door Required: Yes
	• Manipulation of Dosage Form: n/a
	• Special Manipulation for Administration:
Disposal / Spills	• Disposal of Drug Waste: Full- black bin Trace- yellow bin
	• Disposol of Used PPE: yellow bin
	• Spill management: Manage like antineoplastic agents

Last updated: May. 22, 2025

Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
Hazardous Waste BLACK BUCKET/YELLOW BUCKET
Chemotherapy
Look-Alike/Sound-Alike mitoMYcin confused with mitoXANTRONE

UpToDate Lexidrug

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556

This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.